Purchase Order 36C26125P0123
Award Date
1/10/23
Potential Completion Date
3/31/25
Potential Value
$75K
Federal Agency
Veterans Integrated Service Network 21
Awardee
Accredo Health Group, Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Bartlett, TN 38134, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) awarded a firm fixed price purchase order contract to Accredo Health Group, Inc., a for-profit pharmacy benefit management company, to provide OXERVATE 0.002% eye drops. The contract has a potential value of $149,388.16 and a completion date of June 30, 2023. As a prime contractor, Accredo Health Group supports the VHA by delivering specialty pharmaceutical products to VA medical centers and facilities nationwide....
The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) awarded a firm fixed price purchase order contract to Accredo Health Group, Inc. to provide OXERVATE eye drop medication. FDA approval for OXERVATE was granted in 2018 to the manufacturer, Dompe, an Italian company. Accredo Health Group, a specialty pharmacy services provider, is an authorized distributor of OXERVATE. The contract, valued at $140,264.96, does not have a set-aside designation and was awarded on July 1,...
This firm fixed-price purchase order contract was awarded by the Department of Veterans Affairs (VA) to Accredo Health Group, Inc., a for-profit pharmacy benefit management company, for the delivery of OXERVATE OPHTHALMIC SOLUTION. The contract, valued at $79,232.80, does not have a set-aside designation. The solicitation was issued by the Lebanon VA Medical Center to procure a single 56ml bottle of Oxervate, an ophthalmic solution used to treat corneal ulcers and prevent blindness. This was...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 6 (VA-VHA VISN 6) awarded a $149,388 firm fixed price purchase order to Accredo Health Group, Inc. of Bartlett, Tennessee for the delivery of Oxiviate Ophthalmic Solution. As a prime contractor supporting VA-VHA pharmaceutical needs, Accredo will provide the specified eye medication to VA medical facilities in the region under the terms of this one month contract running from August 18th to...
This federal contract award, valued at $80,409.58, was issued by the Department of Veterans Affairs' Veterans Integrated Service Network 19 (VISN 19) to Accredo Health Group, Inc., a for-profit pharmacy benefit management company and subsidiary of Express Scripts. The contract is a firm fixed-price purchase order for the delivery of 9 pharmacy orders across multiple VISN locations, including medications to treat conditions such as pulmonary arterial hypertension, neuropathic lysosomal storage...
This is a $40,697.68 firm fixed-price purchase order contract awarded by the U.S. Department of Veterans Affairs (VA) to Accredo Health Group, Inc., a for-profit pharmacy benefit management company. The contract is for the supply of specialty pharmaceutical products, including medications to treat pulmonary arterial hypertension, neuropathic lysosomal storage disorders, and ophthalmic disorders. The contract has an ultimate completion date of March 14, 2025 and is part of the VA's Veterans...
The U.S. Department of Veterans Affairs (VA) awarded a $81,342.18 firm fixed-price purchase order contract to Accredo Health Group, Inc., a for-profit pharmacy benefit management company, to provide the specialty pharmaceutical TYVASO. The contract, which does not have a set-aside designation, is to support the VA's Veterans Integrated Service Network 21 (VISN 21) and has an ultimate completion date of September 30, 2022. Accredo Health Group, Inc. is a key distributor of complex and...
This is a $103,003.20 firm fixed-price purchase order contract awarded by the U.S. Department of Veterans Affairs (VA) to Accredo Health Group, Inc., a for-profit pharmacy benefit management company specializing in specialty pharmaceutical services. The contract is for the delivery of various complex and high-value medications, primarily to support the VA's Veterans Integrated Service Network (VISN) healthcare facilities. Key medications provided under this contract include drugs used to treat...
The U.S. Department of Veterans Affairs (VA) awarded a $10,708.63 firm fixed-price purchase order to Accredo Health Group, Inc., a for-profit pharmacy benefit management company, for the emergency procurement of the specialty medication Lumryz (sodium oxybate). The contract has an ultimate completion date of May 9, 2025 and does not utilize a set-aside designation. Accredo Health Group, Inc. is a subsidiary of Express Scripts and specializes in providing specialty pharmaceutical services and...
This is a firm fixed-price purchase order contract awarded by the U.S. Department of Veterans Affairs (VA) to Accredo Health Group, Inc., a for-profit pharmacy benefit management company that specializes in specialty pharmaceutical services. The contract, valued at $75,576.09, is for the delivery of Uptravi medicine to support the VA's Veterans Integrated Service Network (VISN) 6. The contract does not have a set-aside designation and was awarded on October 27, 2020, with a completion date of...